Mauna Kea Technologies publishes corporate presentation on Cellvizio cellular imaging platform and growth pillars

  • Mauna Kea Technologies outlined a 2026 inflection plan to scale Cellvizio, citing adoption momentum in pancreatic cyst diagnosis.
  • U.S. pancreatic cyst opportunity sized at about USD 300 million, including USD 200 million system sales and USD 100 million annual recurring revenue.
  • Pancreatic cyst proposition tied to CPT 43252 reimbursement uplift to USD 3,939 from USD 1,960 per case, adding USD 1,979 revenue.
  • CellTolerance positioned as a new self-pay IBS diagnostic market with a stated USD 6 billion global TAM, targeting 1 billion patients.
  • Financial reset highlights include EUR 27 million debt eliminated, EUR 20 million equity restored, operating losses down 70% since 2020.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mauna Kea Technologies SA published the original content used to generate this news brief on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.